176 related articles for article (PubMed ID: 27862305)
21. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues.
Hassan NM; Hamada J; Kameyama T; Tada M; Nakagawa K; Yoshida S; Kashiwazaki H; Yamazaki Y; Suzuki Y; Sasaki A; Nagatsuka H; Inoue N; Moriuchi T
Asian Pac J Cancer Prev; 2011; 12(4):947-51. PubMed ID: 21790231
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD109 in oral squamous cell carcinoma and its clinical significance.
Chen H; Junji Xu ; Ge R; Liu C
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):145-149. PubMed ID: 38814222
[TBL] [Abstract][Full Text] [Related]
27. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
28. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
29. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
30. Overexpression and clinicopathological significance of homeobox gene Quox-1 in oral squamous cell carcinoma.
Zhu F; Li J; Li WX; Liu ZC; Long X
J Biochem Mol Biol; 2004 Nov; 37(6):671-5. PubMed ID: 15607025
[TBL] [Abstract][Full Text] [Related]
31. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
[TBL] [Abstract][Full Text] [Related]
32. Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results.
Toyoshima T; Koch F; Kaemmerer P; Vairaktaris E; Al-Nawas B; Wagner W
J Oral Pathol Med; 2009 Jul; 38(6):530-4. PubMed ID: 19222712
[TBL] [Abstract][Full Text] [Related]
33. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
[TBL] [Abstract][Full Text] [Related]
35. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
36. Influence of class M1 glutathione S-transferase (GST Mu) polymorphism on GST M1 gene expression level and tumor size in oral squamous cell carcinoma.
Koch FP; Kämmerer PW; Kämmerer P; Al-Nawas B; Brieger J
Oral Oncol; 2010 Feb; 46(2):128-33. PubMed ID: 20060357
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]